Okyo Pharma News - OKYO

Company Name	Stock Ticker Symbol	Market	Type
Okyo Pharma Limited	OKYO	London	Ordinary Share

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	91.00	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			91.00	91.00

more quote information »

Industry Sector
MINING

Recent News

Date	Time	Source	Heading
4/08/2024	19:00	UKREG	OKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
4/02/2024	07:00	UKREG	OKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
3/22/2024	07:00	UKREG	OKYO Pharma Announces OK-101 Successfully Achieved..
3/21/2024	07:00	UKREG	OKYO Pharma to Host Key Opinion Leader Event to Discuss New..
3/20/2024	07:00	UKREG	OKYO Pharma to Release New and Comprehensive Data from Phase..
2/09/2024	07:36	IHNW	OKYO Pharma Receives FDA Approval of IND for OK-101 in..
2/09/2024	07:00	UKREG	OKYO Pharma Receives FDA Approval of IND for OK-101 in..
1/31/2024	07:00	UKREG	OKYO Pharma Announces Distinguished Ophthalmologists with..
1/08/2024	07:00	GLOBE	OKYO Pharma Announces OK-101 Successfully Achieved..
1/05/2024	09:30	GLOBE	OKYO Pharma to Present at the Biotech Showcase Conference in..
12/04/2023	07:00	GLOBE	OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
10/31/2023	07:00	GLOBE	OKYO Pharma Announces $5.84 Million Cash Raise and Payables..
10/09/2023	07:00	GLOBE	OKYO Pharma Announces Filing of an Investigational New Drug..
10/05/2023	07:00	GLOBE	OKYO Pharma Announces Positive Safety Data Profile for the..
9/15/2023	07:00	GLOBE	OKYO Pharma Announces Closing of $4.0 Million Registered..
9/14/2023	09:15	GLOBE	OKYO Pharma Announces Pricing of $4.0 Million Registered..
9/14/2023	08:45	GLOBE	OKYO Pharma Limited Announces Withdrawal of Public Offering
9/13/2023	16:05	GLOBE	OKYO Pharma Announces Public Offering of Ordinary Shares
9/08/2023	07:00	GLOBE	OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
8/30/2023	07:00	GLOBE	OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
8/29/2023	07:00	GLOBE	OKYO Pharma Limited Regains Compliance with Nasdaq Listing..
8/15/2023	09:00	GLOBE	OKYO Pharma Limited Reports Annual Results for the Twelve..
7/31/2023	02:18	GLOBE	OKYO Pharma Limited Announces Withdrawal of Public Offering
7/28/2023	17:25	GLOBE	OKYO Pharma Announces Proposed Public Offering of Ordinary..
7/28/2023	17:05	GLOBE	OKYO Pharma Limited Receives Nasdaq Deficiency Notice
7/28/2023	07:01	GLOBE	OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
7/27/2023	11:30	GLOBE	OKYO Pharma Announces Appointment of William A. Clementi as..
6/06/2023	09:30	GLOBE	OKYO Pharma Announces Randomized Segment Now Underway in..
5/22/2023	03:15	UKREG	OKYO Pharma Limited London Stock Exchange Delisting
5/22/2023	03:00	UKREG	London Stock Exchange Notice Cancellation - OKYO PHARMA..
5/19/2023	06:22	ALNC	IN BRIEF: Okyo Pharma to move shares to New York with London..
5/19/2023	03:00	RNSNON	OKYO Pharma Limited ADS Program collapse
5/15/2023	02:00	UKREG	OKYO Pharma Limited Change of Record Time and Last Day of..
5/11/2023	09:27	ALNC	IN BRIEF: Okyo Pharma delays delisting from London trading..
5/11/2023	07:00	RNSNON	OKYO Pharma Limited Webull Corporate Communications Service..
5/11/2023	02:00	UKREG	OKYO Pharma Limited Change of Delisting Date to 22 May 2023
5/03/2023	08:00	UKREG	OKYO Pharma Limited Result of Meeting
5/03/2023	02:00	GLOBE	OKYO Pharma Announces Presentations at the American Society..
5/02/2023	15:16	ALNC	TRADING UPDATES: Knights Group buys St James Law and Baines..
5/02/2023	02:00	GLOBE	OKYO Pharma Announces First-Patient First-Visit for Phase 2..
5/02/2023	02:00	UKREG	OKYO Pharma Limited First-Patient First-Visit for Phase 2..